Dr. Anas Kayal, MD

Dr. Kayal practices at U.S. Renal Care Oceanside Dialysis in Oceanside, California.

Dr. Kayal's NPI, 1851376917, was assigned on December 13, 2005. Dr. Kayal graduated from Damascus University Faculty of Medicine in 2001. Dr. Kayal holds California license 112450.

Dr. Kayal's primary practice is U.S. Renal Care Oceanside Dialysis, at 2227 South El Camino Real, Suite B, Oceanside, CA 92054 in San Diego County. The practice phone is (760) 757-1838.

Dr. Kayal's primary practice is U.S. Renal Care Oceanside Dialysis in Oceanside, California. Dr. Kayal is also affiliated with Loma Linda University Medical Center. The medical group on file is Rheumatology and Arthritis Medical Clinic. Dmand AI also links Dr. Kayal to 4 more hospitals, 4 dialysis centers, 3 medical groups, 2 skilled nursing facilities and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kayal practices, 13 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kayal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kayal is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kayal's licenses on file in 9 states: California, Louisiana, Texas, Michigan, South Carolina, Washington, Wyoming, Iowa and Wisconsin.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, electrolyte disorders, fluid and electrolyte imbalances and kidney failure among the conditions Dr. Kayal treats.

CMS data shows 7,064 Medicare services from Dr. Kayal across 17 procedure codes in 2024, for 808 Medicare patients. Medicare paid $572,515 for them.

CMS counts 808 Medicare patients who saw Dr. Kayal in 2024. The largest group is 65 to 74, with 293 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 80% are also on Medicaid. Their average risk score is 3.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kayal's median patient age at 68, with 52% women.

In 2024, Dr. Kayal wrote 2,337 Medicare Part D claims for 490 patients. 89% of them were for generic drugs. CMS names the drug for 1,898 of them, across 51 drugs with 11 or more claims each, at $165,559 in total drug cost. In 2023, CMS named 2,111 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 73 out of 100 for Dr. Kayal for performance year 2024, reported individually. Dr. Kayal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kayal as offering telehealth.

Dmand AI links 3 papers to Dr. Kayal, published from 2007 to 2014. Dr. Kayal's most frequent co-authors are Akram Al-Makki, MD, Mazen Kherallah, MD and Lina Murad, MD.

CMS Open Payments shows 264 general payments to Dr. Kayal from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $1,310.

Dr. Kayal graduated from Damascus University Faculty of Medicine in 2001.

Dr. Kayal is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.